In utero fetal muscle biopsy alters diagnosis and carrier risks in Duchenne and Becker muscular dystrophy

Fetal Diagn Ther. 1995 Mar-Apr;10(2):71-5. doi: 10.1159/000264206.

Abstract

Objectives: We have previously shown that Duchenne muscular dystrophy (DMD) can be diagnosed by fetal muscle biopsy and immunohistochemical staining showing the absence of dystrophin. In Becker muscular dystrophy (BMD), there is a variable dystrophin staining pattern.

Study design: A 26-year-old, gravida 5, para 1, SAB 2, VIP 1, white female had a son with the diagnosis of BMD, with no other affected family members. In the current pregnancy, the male fetus inherited the same X chromosome.

Results: Fetal muscle biopsy revealed no dystrophin, consistent with the diagnosis of DMD, prompting re-analysis of the sibling whose diagnosis was then changed to DMD.

Conclusions: Molecular techniques in prenatal diagnosis in this case not only led to the diagnosis of a severe disorder in the current pregnancy, but changed the diagnosis in another child, allowing for more appropriate counseling of this couple.

Publication types

  • Case Reports

MeSH terms

  • Abortion, Induced
  • Adult
  • Biopsy / methods
  • Diagnostic Errors
  • Dystrophin / analysis
  • Female
  • Fetal Diseases / diagnosis*
  • Genetic Counseling
  • Heterozygote
  • Humans
  • Male
  • Muscle, Skeletal / chemistry
  • Muscle, Skeletal / pathology
  • Muscular Dystrophies / diagnosis*
  • Muscular Dystrophies / pathology
  • Pregnancy
  • Prenatal Diagnosis / methods*

Substances

  • Dystrophin